Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
The e.coli derived HEV Mosaic-S protein contains 4 HEV immunodominant regions from the ORF2 and ORF3 having a total molecular mass of 33 kDa. The 4 HEV regions is a part of the 12 HEV regions. HEVMosaic-S comprises of epitope N- terminus of ORF2 and epitope of approximately 500?±100aa of ORF3.
Greater than 95% by SDS-PAGE
25 mM Tris-HCl, 25 mM EDTA, 25 mM Urea, 50% glycerol.
Store at -20°C. Avoid freeze/thaw cycles.
For research use only.
About HEV / Hepatitis E Virus
Hepatitis E is a viral hepatitis (liver inflammation) caused by infection with a virus called hepatitis E virus (HEV). It is one of five known human hepatitis viruses: A, B, C, D, and E. HEV is a positive-sense single-stranded RNA icosahedral virus with a 7.5 kilobase genome. HEV has a fecal-oral transmission route. Infection with this virus was first documented in 1955 during an outbreak in New Delhi, India. A preventative vaccine (HEV 239) is approved for use in China.